CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Cefizox In Dextrose 5% In Plastic Container patents expire, and what generic alternatives are available?
Cefizox In Dextrose 5% In Plastic Container is a drug marketed by Astellas and is included in one NDA.
The generic ingredient in CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What are the global sales for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 1 |
| DailyMed Link: | CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Khartoum | Phase 4 |
| Ministry of Health, Sudan | Phase 4 |
See all CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials
US Patents and Regulatory Information for CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astellas | CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER | ceftizoxime sodium | INJECTABLE;INJECTION | 050589-001 | Oct 3, 1984 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Astellas | CEFIZOX IN DEXTROSE 5% IN PLASTIC CONTAINER | ceftizoxime sodium | INJECTABLE;INJECTION | 050589-002 | Oct 3, 1984 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
